Applications of (+)-Dibenzoyl-D-Tartaric Acid Monohydrate in Industrial Manufacturing

We supply (+)-Dibenzoyl-D-Tartaric Acid Monohydrate to leading industrial clients who require stringent purity and chiral selectivity for high-value manufacturing. Our production supports key application sectors where regulatory compliance, precise dosage, and process compatibility are critical, enabling downstream users to achieve demanding standards in pharmaceuticals, fine chemicals, and other advanced material syntheses.

1. Chiral Resolution in Active Pharmaceutical Ingredient Synthesis

This material serves as a resolving agent in the separation of racemic mixtures for the production of enantiomerically pure pharmaceutical intermediates and APIs. Manufacturers select it for its high selectivity and established performance in large-scale enantiomer purification, critical for regulatory registry and global distribution.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• European Pharmacopoeia (Ph. Eur.) monographs on chiral compounds
• US FDA cGMP guidelines (21 CFR Part 210 & 211)
• China Pharmacopoeia requirements

Typical usage ratio

• Stoichiometric or 1:1 molar ratio relative to the racemic substrate; process chemists adjust based on the optical purity required and specific enantiomeric excess targets.

Downstream process integration

• Resolved in the early to mid-stage production step post-synthesis of racemate, followed by crystallization, filtration, and subsequent separation and recovery stages.

Final product types

• Enantiopure active pharmaceutical ingredients (e.g., beta-blockers, antihistamines, anti-epileptics)
• Chiral intermediates for small-molecule drug synthesis

2. Production of Chiral Catalysts for Asymmetric Synthesis

Many catalyst manufacturers incorporate (+)-Dibenzoyl-D-Tartaric Acid Monohydrate into ligand design or catalyst frameworks, utilizing its enantiopurity to ensure targeted asymmetric induction for downstream pharmaceutical or agrochemical production. The material enables consistent and regulated enhancement of selectivity in high-value catalytic systems.

Industry compliance standards

• ISO 9001:2015 Quality Management for fine chemical manufacturing
• AICM Responsible Care® guidelines
• REACH registration (EU Regulation 1907/2006) for chemical manufacturing and handling

Typical usage ratio

• 0.5—2 mol% of catalyst or ligand synthesis batch, adjusted according to desired catalyst loading and enantioselectivity performance in downstream processes.

Downstream process integration

• Reacted during ligand construction phase, followed by complexation with metal centers and characterization for enantiomeric excess and catalytic activity testing.

Final product types

• Chiral phosphine or amine ligands
• Asymmetric hydrogenation or epoxidation catalysts supplied for pharmaceutical and agrochemical production lines

3. Quality Control Reference Substance for Chiral Purity Analysis

Analytical laboratories use the monohydrate as a certified reference standard to calibrate chromatographic systems and validate chiral separation methods. It plays a role in ensuring precise quantitation of stereochemistry during process validation, batch release, and regulatory submissions where traceable enantiopurity is required.

Industry compliance standards

• United States Pharmacopoeia (USP) General Chapters: Chiral Purity & Analysis
• European Pharmacopoeia (Ph. Eur.) 2.2.46: Chromatographic Separation Techniques
• ISO/IEC 17025 Accreditation for Testing & Calibration Laboratories

Typical usage ratio

• 1–10 mg per analysis, as determined by specific HPLC, GC, or capillary electrophoresis calibration requirements and detector sensitivity.

Downstream process integration

• Prepared as a standard or spiking agent during analytical method development, used for system suitability testing, method validation and as a control sample during product release QA/QC.

Final product types

• Pharmaceutical and fine chemical analytical standard kits
• Certified reference materials (CRMs) for laboratory quality management

4. Optical Resolution of Amines in Agrochemical Intermediate Manufacturing

The resolving agent function of the monohydrate also extends to optical separation of racemic amines which are key building blocks in the synthesis of agrochemical actives such as herbicides and insecticides. Agrochemical companies favor its use due to its well-documented separation efficiency, enabling production-scale access to chiral intermediates required for targeted biological activity in regulated markets.

Industry compliance standards

• FAO/WHO Joint Meeting on Pesticide Specifications (JMPS) requirements
• ISO 9001:2015 and ISO 14001:2015 Environmental Management
• REACH compliance for intermediate handling and transport

Typical usage ratio

• Equimolar or slightly excess (1.0–1.2:1) relative to the racemic amine substrate, with ratio selection based on downstream chromatographic purity or regiochemistry specifications.

Downstream process integration

• Added during chemical resolution stage after amine synthesis, followed by crystallization, separation of diastereomeric salts, and regeneration to yield optically active amine components for further coupling or cyclization steps.

Final product types

• Chiral amine intermediates for selective herbicides and insecticides
• Enantiomerically pure active ingredients for crop protection

5. Fine Chemical Synthesis for Fragrance and Flavor Enantiomer Production

Specialty chemical producers employ the monohydrate to resolve racemic alcohols, acids, or amines crucial to the production of chiral fragrance and flavor molecules, where sensory properties depend on absolute configuration. Manufacturers prioritize use of this resolving agent for precise adjustment of olfactory and taste profiles according to international safety and labeling standards.

Industry compliance standards

• IFRA (International Fragrance Association) standards
• Food Chemicals Codex (FCC) requirements for flavor ingredients
• ISO 22716 GMP for cosmetic ingredient manufacturing

Typical usage ratio

• Ranging from 1:1 up to 1.5:1 molar ratio depending on substrate reactivity and resolution efficiency; formulation scientists determine exact proportion based on batch scale and desired organoleptic purity.

Downstream process integration

• Incorporated post-racemic synthesis to form diastereomeric salts or derivatives, followed by fractionation, solvent exchange, and recovery of optically pure fragrance/flavor precursors for blending.

Final product types

• Chiral flavoring agents (e.g., (R)- or (S)-menthol, carvone)
• Optically pure fragrance compounds for personal care and luxury cosmetic products